A B S T R A C T
Background. Recently, transplant societies have had to change their allocation policies to counter global organ shortages. However, strategies differ significantly and long-term outcomes and cross-regional applicability remain to be evaluated. Methods. Therefore, we retrospectively analysed the Kidney Donor Profile Index (KDPI) of 987 adult kidney transplants at our centre using data from the Organ Procurement and Transplantation Network (OPTN) as a reference. Results. In our cohort, the median KDPI was 66%, with a higher proportion of >85% KDPI kidneys compared with the US cohort (32.3% versus 9.2%). Among elderly patients (!65 years of age), 62% received >95% KDPI kidneys, which were primarily allocated within the Eurotransplant Senior Program (ESP). After 10 years, the rate of death-censored graft survival was 70.5%. Recipients of >85% KDPI kidneys were significantly older, demonstrating higher mortality, poorer graft survival and lower estimated glomerular filtration rate. Patients receiving !99% KDPI kidneys had a satisfactory 5-year death-censored graft survival (72.9%). The 5-year survival rate of patients living with a functioning graft exceeded the matched OPTN data in the whole KDPI range, despite a higher proportion of elderly recipients. Multivariate analysis revealed KDPI as an independent risk factor for graft loss (hazard ratio 1.14/10%, P < 0.001), although C-statistics of 0.62 indicated limited discriminative ability for individuals. Conclusion. The analysis demonstrated KDPI as a potentially useful tool for donor quality assessment in a European cohort. Most importantly, our analysis revealed acceptable outcomes even for very high KDPI kidneys.
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I N T R O D U C T I O N
In recent years, allocation policies have changed to meet the growing need for donor organs [1, 2] . This has led to an increased use of expanded criteria donor (ECD) kidneys, defined as donors !60 or 50-59 years of age with at least two of the following characteristics: serum creatinine >1.5 mg/dL, cerebrovascular death and hypertension [3] . Despite a higher relative risk of graft loss, the utilization of ECD kidneys has increased the donor pool and generated acceptable outcomes [4] [5] [6] .
To improve the utilization of organs, a new Kidney Allocation System (KAS) was implemented in the USA in December 2014. It includes the concept of longevity matching, by which higherquality kidneys based on the Kidney Donor Profile Index (KDPI) are preferentially allocated to recipients with the longest predicted post-transplant survival. The KDPI is derived from the Kidney Donor Risk Index (KDRI), which was developed by Rao et al. [7] in 2009 to improve prediction of graft outcomes. Because the KDRI uses 10 donor characteristics instead of a maximum of 4, it allows a more nuanced prediction of graft outcomes. The KDPI is a percentile score ranging from 0% to 100%, referring to the median donor, defined as a KDRI of 1.0, of the previous year of all transplants. A donor KDPI >85% was originally considered to be comparable to an ECD kidney [6] [7] [8] [9] .
In Europe, the Eurotransplant Senior Program (ESP) was introduced in 1999, alongside the already existing Eurotransplant Kidney Allocation System (ETKAS). The ESP was established to address organ shortages and to increase the utilization of marginal donor kidneys. Through the ESP, elderly recipients (!65 years of age) receive kidneys from donors (!65 years of age) to achieve a functional match. By local allocation, neglecting human leucocyte antigen (HLA) matching, the program aims to shorten cold ischaemia time (CIT) to optimize graft outcome [10, 11] . A 5-year analysis of the ESP has demonstrated acceptable outcomes (death-censored graft survival of 67%), with a high proportion of deaths with a functioning graft [4] .
This study was conducted to investigate the utility of the KDPI in a European cohort and evaluate related outcomes and its prediction ability in European patients. Moreover, the analysis was aimed at comparing these results to recent US data by describing the differences in both approaches.
M A T E R I A L S A N D M E T H O D S

Study subjects
This retrospective single-centre study included 987 adult patients who successively received a deceased donor kidney transplantation from 1991 to 2014 at one of the three transplant units at the Charité Berlin with corresponding donor data. Our electronic patient database [12] and the Eurotransplant Network Information System (ENIS) were used for the data collection. The transplant outcome was observed over a period of up to 23.6 years (mean 7.2) post-transplant. All study procedures were approved by the institutional Ethics Committee (EA1/048/14).
Calculation of KDRI and KDPI
For calculation of the KDRI, 10 donor characteristics [age, height, weight, ethnicity, hypertension, diabetes, cause of death (anoxia, cerebrovascular incident/stroke, traumatic head injury, tumour, other), serum creatinine (0.01-4 mg/dL) and hepatitis C virus (HCV) status] were used. Based on the KDRI values, the KDPI score (%) for each kidney was determined using the Organ Procurement and Transplantation Network (OPTN) mapping table and the median donor of 2014 as a reference [13] . In case of missing information on diabetes or hypertension status, the KDPI was determined by mean substitution of individual missing values according to OTPN methods [14] . Because information on ethnicity is not filed in Germany, all donors were classified as Caucasian according to German epidemiology. Donation after circulatory death (DCD) is not permitted in Germany.
Other definitions
Standard criteria donor (SCD) and ECD kidneys were defined using the United Network for Organ Sharing (UNOS) definition [15] . The median estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease formula [16, 17] ; GFR ¼ 0 mL/min/1.73 m 2 was imputed for patients suffering from graft failure.
Immunosuppression
Most patients initially received a standard immunosuppressive protocol including induction therapy (anti-interleukin-2 receptor antibody), calcineurin inhibitor, mycophenolate and steroids. The tapering of steroids was performed with the intention of achieving a steroid-free regimen after the first year, if no rejection episodes had occurred. The immunosuppressive strategy in elderly compared with younger kidney transplant recipients was not different with regard to initial dosing and target levels of calcineurin inhibitor, mycophenolate dosing and steroid withdrawal.
In-house policy for the acceptance of ECD kidneys ECD kidneys offered to patients on our waiting list undergo extensive screening by an interdisciplinary team, including a transplant nephrologist, a urologist, the dialysis team or treating physician and the patient. Besides kidney function and the conventional renovascular risk factors, we focus on proteinuria, circumstances of donor brain death and aim to achieve an appropriate weight match of donor and recipient. Donor kidney biopsies were not part of the decision.
Data analysis
The distribution of patient characteristics in our cohort as well as the KDPI rates and discard rates were compared with those of the US population by using data from the OPTN/ Scientific Registry of Transplant Recipients (SRTR) annual data report [1] . Survival data were assessed with the Kaplan-Meier method and log-rank test. Donor and recipient characteristics are shown as means with standard deviation or, in case of a non-normal distribution, as median with interquartile range (IQR). The data were analysed by the chi-square test, analysis of variance (ANOVA) and t-tests for independent variables. In case of a non-parametric distribution, the Kruskal-Wallis or Mann-Whitney test was used. The significance level was set to a ¼ 0.05. Univariate and multivariate analyses were conducted using the Cox proportional hazard models with a confidence interval of 95%. A stepwise backward elimination, including the recipient age, donor age, CIT, delayed graft function (DGF), number of HLA mismatches, KDPI, donor hypertension, donor diabetes and donor cerebrovascular death, was used for the multivariate analysis. The proportional hazard assumption was tested by Schoenfeld residuals for each covariate over time. A time-dependent receiver operating characteristic (ROC) curve estimation from censored survival data was conducted with R version 3.2.3 (R Project for Statistical Computing, Vienna, Austria) using the method of Heagerty et al. [18] . SPSS version 22 for Windows (IBM, Armonk, NY, USA) was used for statistical analysis.
R E S U L T S
Patient characteristics
Patients were categorized by both the donor KDPI (according to OPTN/SRTR analyses) and donor age (< or !65 years, according to the Eurotransplant allocation system). Patient characteristics are shown in Table 1 . In the >85% KDPI group, 71% of the kidneys were allocated within the ESP. In this category, the recipient age and number of mismatches were significantly higher, whereas CIT was shorter compared with the other groups. A previous kidney transplantation was more frequent in the lower KDPI categories. The proportion of ECD kidneys was 2.5% in the low (21-34%), 40% in the moderate (35-85%) and 99% in the high (>85%) KDPI group. Overall, the median and mean KDRI in our cohort were 1.17 (IQR 0.91-1.65) and 1.28 6 0.49, respectively. This translated into a median KDPI of 66% (IQR 41-92) and a mean KDPI of 63 6 30%, based on OPTN 2014 data as a reference. The median and mean KDPI in elderly transplant recipients (!65 years) were 97% (IQR 20-100) and 92 6 13%. In this group, 62% of patients received a >95% KDPI kidney. Figure 1 depicts the donor KDPI of transplanted kidneys in all patients and elderly patients. The comparison of transplanted kidneys by KDPI category with the US cohort is shown in Figure 1C . The proportion of >85% KDPI kidneys was markedly higher in our cohort compared with the UNOS database [32.3% (1991-2014) versus 9.2% (2002-14)]. Correspondingly, the proportion of <35% KDPI kidneys was lower (20.3% versus 39.6%). Table 2 displays the distribution of the recipient age at our centre compared with the US cohort, which shows a significant difference in the proportion of elderly transplant recipients (!65 years of age).
Patient and graft survival
After 2, 5 and 10 years, the overall graft survival rates (absence of graft failure or death) of patients in our cohort with a median KDPI of 66% were 88.3% (95% CI 86.3-90.3), 76.0% Figure 2A -C. The KDPI group >85% showed significantly worse outcomes (log-rank P < 0.001). However, death-censored graft survival rates were comparable within the KDPI >85% group after 5 years, despite increasing KDPI levels (KDPI 86-95: 72.4%; 96-98: 77.1% and !99: 72.9%). The ideal KDPI group <20% did not exceed the results of the lower group with KDPI 21-34% in our cohort.
Graft function by KDPI category
Despite similar median donor creatinine values among the KDPI groups (0.8, 0.8, 0.9 and 1.0 mg/dL), eGFR levels showed significant differences. At 1 year post-transplant, the median eGFR levels were 65.8, 60.4, 46.1 and 35.2 mL/min/1.73 m 2 for the four KDPI groups. However, all groups demonstrated similar slopes of decreasing graft function ( Figure 2D ). Even the group of >85% KDPI kidneys demonstrated a flat slope of À1.2 mL of GFR loss per year.
DGF occurred more frequently in the higher KDPI groups, although DGF rates did not further increase in the highest KDPI categories (KDPI <20: 30%; 21-34: 26%; 35-85: 46% and >85: 49%).
To compare long-term outcomes of our European cohort with the US cohort in terms of living with a functioning graft, KDPI quintiles of the European cohort were established and matched with OPTN data from 2000 to 2007 [20] . At 5 years post-transplant, the European cohort exceeded the rates of the US cohort at all KDPI levels ( Figure 3 ).
Prediction of graft loss
Our analysis showed a significant association of high KDPI, donor age, prior kidney transplantation, number of HLA mismatches and donor hypertension with premature graft loss. Multivariate analysis revealed KDPI, CIT and HLA mismatches as independent predictors of lower graft survival, whereas older recipient age prevented death-censored graft loss ( Table 3 ). The ROC of death-censored graft survival data using the method of Heagerty et al. [18] yielded an area under the curve of 0.62 over 10 years post-transplant.
D I S C U S S I O N
The KDPI was developed from UNOS/SRTR data [7, 14] in a US cohort and derived from the KDRI, which was further validated in European and Asian cohorts [21] [22] [23] . In our analysis, the KDPI also predicted graft survival in a European population, leading to worse outcomes with increasing KDPI. The multivariate analysis of our cohort revealed KDPI as an independent predictor of graft loss. However, the utility of prediction for the individual was limited, as the C-statistic of 0.62 provided only fair predictive accuracy. In fact, the discriminatory power was limited within KDPI categories at both ends of the range in our cohort. This is in line with the original analysis by Rao et al. [7] , who reported a similar discrimination ability. Nevertheless, overall prediction accuracy can be considered remarkable, taking into account the prediction span of 10 years post-transplant and the fact that it was based on donor factors pre-transplant only.
Our cohort differed significantly from the US population. Recipients were older and the proportion of elderly patients (!65 years) was higher (26.4% versus 15.2%). In addition, our patients received older kidneys, which led to higher KDPIs, as evidenced by a 3-fold higher proportion of KDPI !85% kidneys (32.3% versus 9.2%). In contrast, the US cohort contained twice as many kidneys with a KDPI 35% (20.3% versus 39.6%). Due to the dramatic organ shortage in Germany, the average waiting times in our cohort for blood groups AB, A, O and B were 3.1, 5.1, 6.2 and 4.4 years, respectively, compared with 2, 3, 5 and 6 years in the US cohort [9, 24] . Despite the high proportion of elderly patients and high KDPI kidneys (>85%) resulting in a median KDPI of 66%, the overall graft survival rates were acceptable, with 76.0% at 5% and 54.4% at 10 years. Although unfavourable baseline variables likely impaired graft outcome in our cohort, the living with a functioning graft rates exceeded the US results over the whole range of KDPI levels.
Several important aspects have to be considered when interpreting these findings: Of >85% KDPI kidneys, 71% were allocated in the ESP, leading to significantly higher recipient and donor age, higher numbers of mismatches and a reduced CIT in this group. As expected, the group of >85% KDPI showed significantly worse overall and death-censored graft survival. However, we believe that a 10-year death-censored graft survival of 62% is acceptable. Within our cohort, we observed similar 5-year deathcensored graft survival rates in the >85% KDPI group (KDPI 86-95: 72.4%; 96-98: 77.1% and !99: 72.9%), demonstrating that acceptable outcomes can be achieved with very high KDPI kidneys. Similarly, DGF rates were comparable between the 35-85% and >85% KDPI groups without a further increase, which suggests that other factors besides KDPI are equally important. In our cohort, KDPI stratification led to clear differences in imputed eGFR. Nevertheless, median imputed eGFR levels of >85% KDPI kidneys showed a flat slope of 1.2 mL/year, from 35.2 to 24.7 mL/min/1.73 m 2 over 10 years, resembling a reasonable graft function. In summary, we believe these findings suggest a good functional match of elderly kidneys allocated to elderly patients. This is in line with the initial analysis of the ESP by Frei ). eGFR was calculated using the Modification of Diet in Renal Disease formula [19] .
Assessment of the KDPI in a European cohort et al. [4] , which showed only a limited impact on graft and patient survival compared with the standard allocation, while improving the utilization of ECD kidneys and reducing the waiting time of elderly recipients [4] .
Recently, another study by Jay et al. [25] compared preemptive and non-preemptive transplantation of >85% KDPI kidneys in recipients >60 years of age with those remaining on the waiting list. After 2 years, transplanted patients had a significantly lower mortality risk than patients remaining on dialysis [25] . Thus a timely transplant seems to be crucial for elderly patients, even if it provides suboptimal function. Another analysis by Massie et al. [26] found that even higher KDPI kidneys provided a significant benefit compared with patients transplanted at a later point in time receiving better-quality kidneys with a lower KDPI. These results are in accordance with findings by other groups in the USA and Norway, who demonstrated superior survival in a diverse range of patients [27] and even in elderly patients >70 years of age [28, 29] receiving ECD kidneys compared with waiting-list candidates. However, studies from The Netherlands question this hypothesis. In 2010, Snoeijs et al. [30] were able to demonstrate significantly reduced mortality for SCD kidney recipients compared with dialysis. In contrast, dialysis treatment was not inferior to receiving a timely transplantation with an ECD kidney. In addition, a recent analysis confirmed acceptable death-censored graft survival rates in The Netherlands, but it was unable to demonstrate a substantial benefit in survival for elderly patients receiving transplants within the ESP compared with dialysis. In this analysis, only younger kidneys provided a survival benefit for elderly patients [31] .
Despite these reports, discard rates have increased in the USA, especially for high KDPI kidneys. The proportion of discards in the USA for 2012-14 was 18.3% [32] . In the same period, Eurotransplant reported an overall discard rate of only 14% [2] . In our analysis, the median KDPI of transplanted organs was significantly higher than the median KDPI of organs recovered for the purpose of transplantation in the USA in 2014 (66% versus 50%). Notably, in the group of elderly kidney transplant recipients (!65 years of age) in our cohort, 89% received a kidney with a KDPI of 81-100%, of which 50.6% were discarded in the USA in 2012-14, and 62% received a kidney with a KDPI >95%, of which 71.6% were discarded in the USA in 2012-14 [32] . Age matching in the ESP together with the benefit of shorter waiting times facilitates allocation of higher KDPI kidneys in the Eurotransplant region and is a main driver of low discard rates. In addition, some kidneys are utilized by rescue allocation, in which organs are offered competitively to centres if rejected five times for medical reasons [33, 34] . In the USA, discard rates largely vary between centres. The Centers for Medicare and Medicaid Services policy certifies centres based on first-year patient and graft survival metrics and, although accounting for recipient age and donor risk by KDPI, this leads to an increasing reluctance to perform higher-risk transplantations or acceptance of high KDPI kidneys [25, [35] [36] [37] . However, Bae et al. [32] advised caution in using solely the KDPI as a preventive tool to ensure favourable outcomes, because up to 25% of 86-90% KDPI kidneys resemble SCD kidneys by the former classification in their analysis. Such a labelling effect by the KDPI implies the risk of discarding a high proportion of kidneys with a potential for reasonable outcomes. Our analysis emphasizes this point since, within the >85% KDPI kidneys, outcomes are not decreasing with KDPI increments, as would be expected. At the other end of the spectrum, the outcome of the <20% KDPI group was not superior compared with the 21-34% category. This might indicate the potential for longevity matching, which is currently not met by the ETKAS/ESP allocation system.
Finally, another substantial difference of both cohorts is the setting of the respective health care systems. German patients are privileged by full coverage of the transplant procedure, close maintenance monitoring post-transplant and infinite reimbursement for medication. At our centre, patients are seen two to four times a month on a routine basis in the outpatient clinics for the first 3 months and monthly thereafter for the first year. In the following years, the vast majority of patients are monitored at least two to four times a year. This facilitates tailoring immunosuppression, especially in the vulnerable elderly population and high-risk patients, and a timely reaction to issues occurring in the course of transplantation. However, according to Gaston [38] , transplant recipients in the USA, not otherwise disabled or >65 years of age, lose Medicare coverage for immunosuppressive medication at 3 years after the transplant, and even private insurance may restrict full coverage to 1 year. In addition, Gill et al. [39] found >70% of US kidney transplantation programs reporting their patients had serious problems paying for immunosuppressants, and 68% reported deaths and graft losses attributable to cost-related non-adherence. Moreover, other Western countries with different approaches to post-transplantation care and cost coverage showed similar short-term outcomes but demonstrated superior results at 5 and 10 years compared with the USA. This study has its limitations: first, it is a single-centre observational study, and even though follow-up is complete and long, it implies the weaknesses of a retrospective analysis. Second, due to the single-centre setting, patient numbers were limited, and this warrants caution in generalization of these results. Third, we were unable to adjust for different immunosuppression regimens. In addition, the proportions of African Americans, Hispanics and Asians are higher in the US cohort, which might have influenced the results, as inferior outcomes have been reported for ethnic minorities [40] [41] [42] [43] [44] . Moreover, DCD is not permitted in Germany, whereas in the USA the proportion of DCD kidneys gradually increased to 15% in 2013 [1] . However, a significant alteration of outcomes is doubtful, because similar outcomes of DCD kidneys have been reported by US centres [45] [46] [47] .
In conclusion, our analysis demonstrated KDPI as a useful tool for donor quality assessment in a European cohort. However, our results also indicate a limited value of the KDPI at the individual level. Importantly, the study revealed that the allocation of high and very high KDPI kidneys to elderly recipients resulted in acceptable graft survival rates in the long term. A significant proportion of discards may be avoided without compromising graft survival by careful allocation of the best functional match.
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